Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Ruolan Li, Feng Lu, Xue Sun, Liying He, HuXinyue Duan, Wei Peng & ChunJie Wu. (2022) Development and in vivo Evaluation of Hydroxy-α-Sanshool Intranasal Liposomes as a Potential Remedial Treatment for Alzheimer’s Disease. International Journal of Nanomedicine 17, pages 185-201.
Read now
Read now
Mohammad Fazil, Asgar Ali, Sanjula Baboota, Jasjeet K Sahni & Javed Ali. (2013) Exploring drug delivery systems for treating osteoporosis. Expert Opinion on Drug Delivery 10:8, pages 1123-1136.
Read now
Read now
Nadia M. Morsi, Dalia M. Ghorab & Hany A. Badie. (2013) Brain targeted solid lipid nanoparticles for brain ischemia: preparation and in vitro characterization. Pharmaceutical Development and Technology 18:3, pages 736-744.
Read now
Read now
Articles from other publishers (33)
Mohammad Azam Ansari, Takshashila Tripathi, Baskar Venkidasamy, Alan Monziani, Govindasamy Rajakumar, Mohammad N. Alomary, Sami A. Alyahya, Oriane Onimus, Naomi D’souza, Md. Abul Barkat, Ebtesam A. Al-Suhaimi, Ramkumar Samynathan & Muthu Thiruvengadam. (2023) Multifunctional Nanocarriers for Alzheimer’s Disease: Befriending the Barriers. Molecular Neurobiology.
Crossref
Crossref
Linyan Duan, Xingfan Li, Rong Ji, Zhizhong Hao, Mingyue Kong, Xuejun Wen, Fangxia Guan & Shanshan Ma. (2023) Nanoparticle-Based Drug Delivery Systems: An Inspiring Therapeutic Strategy for Neurodegenerative Diseases. Polymers 15:9, pages 2196.
Crossref
Crossref
Prashant Tiwari, Geetha KM, Shweta Shrivastava, Yogita Kumari, Rajni Kant Panik, Pankaj Kumar Singh, Dileep Kumar & Pratap Kumar Sahu. 2023. Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 11. Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 11
262
282
.
Nasrullah Jan, Asadullah Madni, Safiullah Khan, Hassan Shah, Faizan Akram, Arshad Khan, Derya Ertas, Mohammad F. Bostanudin, Christopher H. Contag, Nureddin Ashammakhi & Yavuz Nuri Ertas. (2022)
Biomimetic cell membrane‐coated poly(lactic‐
co
‐glycolic acid) nanoparticles for biomedical applications
. Bioengineering & Translational Medicine 8:2.
Crossref
Crossref
Prabhat Shrestha, Nikita Katila, Sooyeun Lee, Ji Hae Seo, Jee-Heon Jeong & Simmyung Yook. (2022) Methamphetamine induced neurotoxic diseases, molecular mechanism, and current treatment strategies. Biomedicine & Pharmacotherapy 154, pages 113591.
Crossref
Crossref
Chandrani Sarkar, Nagavendra Kommineni, Arun Butreddy, Raj Kumar, Naveen Bunekar & Kishan Gugulothu. 2022. Nanoengineering of Biomaterials. Nanoengineering of Biomaterials
217
260
.
Md Noushad Javed, Md Habban Akhter, Mohamad Taleuzzaman, Md Faiyazudin & Md Sabir Alam. 2022. Fundamentals of Bionanomaterials. Fundamentals of Bionanomaterials
273
292
.
Bibin G. Anand, Qi Wu, Govindarajan Karthivashan, Kiran P. Shejale, Sara Amidian, Holger Wille & Satyabrata Kar. (2021) Mimosine functionalized gold nanoparticles (Mimo-AuNPs) suppress β-amyloid aggregation and neuronal toxicity. Bioactive Materials 6:12, pages 4491-4505.
Crossref
Crossref
Ning Kang, Jin Hua, Lizhen Gao, Bin Zhang & Jiewen Pang. (2021) The Interplay between Whey Protein Fibrils with Carbon Nanotubes or Carbon Nano-Onions. Materials 14:3, pages 608.
Crossref
Crossref
Alesia V. Prakapenka, Alicia M. Quihuis, Catherine G. Carson, Shruti Patel, Heather A. Bimonte-Nelson & Rachael W. Sirianni. (2020) Poly(lactic-co-glycolic Acid) Nanoparticle Encapsulated 17β-Estradiol Improves Spatial Memory and Increases Uterine Stimulation in Middle-Aged Ovariectomized Rats. Frontiers in Behavioral Neuroscience 14.
Crossref
Crossref
Niloufar Choubdar & Sara Avizheh. (2020) Nanotechnology Based Delivery Systems of Drugs Currently Used to Treat Alzheimer’s Disease. Nanoscience & Nanotechnology-Asia 10:3, pages 228-247.
Crossref
Crossref
Gülcem Altinoglu & Terin Adali. (2020) Alzheimer’s Disease Targeted Nano-Based Drug Delivery Systems. Current Drug Targets 21:7, pages 628-646.
Crossref
Crossref
Anmol Dogra, R.S. Narang & Jasjeet K. Narang. (2020) Recent Advances in Nanotherapeutic Interventions for the Treatment of Alzheimer’s Disease. Current Pharmaceutical Design 26:19, pages 2257-2279.
Crossref
Crossref
Josef Jampílek, Katarína Kráľová, Petr Novák & Michal Novák. 2019. Nanobiotechnology in Neurodegenerative Diseases. Nanobiotechnology in Neurodegenerative Diseases
65
138
.
Ram Singh & Geetanjali. (2018) Nanoneuromedicines for Neurodegenerative Diseases. Nanoscience &Nanotechnology-Asia 9:1, pages 58-63.
Crossref
Crossref
Maria Mir, Naveed Ahmed & Asim ur Rehman. (2017) Recent applications of PLGA based nanostructures in drug delivery. Colloids and Surfaces B: Biointerfaces 159, pages 217-231.
Crossref
Crossref
Mukta Agrawal, Ajazuddin, Dulal K. Tripathi, Swarnlata Saraf, Shailendra Saraf, Sophia G. Antimisiaris, Spyridon Mourtas, Margareta Hammarlund-Udenaes & Amit Alexander. (2017) Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer's disease. Journal of Controlled Release 260, pages 61-77.
Crossref
Crossref
Shringika Soni, Rakesh Kumar Ruhela & Bikash Medhi. (2016) Nanomedicine in Central Nervous System (CNS) Disorders: A Present and Future Prospective. Advanced Pharmaceutical Bulletin 6:3, pages 319-335.
Crossref
Crossref
Zhiqiang Jiang, Xiaoyan Dong, Hu Liu, Yongjian Wang, Lei Zhang & Yan Sun. (2016) Multifunctionality of self-assembled nanogels of curcumin-hyaluronic acid conjugates on inhibiting amyloid β-protein fibrillation and cytotoxicity. Reactive and Functional Polymers 104, pages 22-29.
Crossref
Crossref
C. Fornaguera, A. Dols-Perez, G. Calderó, M.J. García-Celma, J. Camarasa & C. Solans. (2015) PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood–brain barrier. Journal of Controlled Release 211, pages 134-143.
Crossref
Crossref
Neng Xiong, Xiao-Yan Dong, Jie Zheng, Fu-Feng Liu & Yan Sun. (2015) Design of LVFFARK and LVFFARK-Functionalized Nanoparticles for Inhibiting Amyloid β-Protein Fibrillation and Cytotoxicity. ACS Applied Materials & Interfaces 7:10, pages 5650-5662.
Crossref
Crossref
C. Fornaguera, N. Feiner-Gracia, G. Calder?, M. J. Garc?a-Celma & C. Solans. (2015) Galantamine-loaded PLGA nanoparticles, from nano-emulsion templating, as novel advanced drug delivery systems to treat neurodegenerative diseases. Nanoscale 7:28, pages 12076-12084.
Crossref
Crossref
Laura Bana, Stefania Minniti, Elisa Salvati, Silvia Sesana, Vanessa Zambelli, Alfredo Cagnotto, Antonina Orlando, Emanuela Cazzaniga, Rob Zwart, Wiep Scheper, Massimo Masserini & Francesca Re. (2014) Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood–brain-barrier: Implications for therapy of Alzheimer disease. Nanomedicine: Nanotechnology, Biology and Medicine 10:7, pages 1583-1590.
Crossref
Crossref
Michela Rosini, Elena Simoni, Andrea Milelli, Anna Minarini & Carlo Melchiorre. (2013) Oxidative Stress in Alzheimer’s Disease: Are We Connecting the Dots?. Journal of Medicinal Chemistry 57:7, pages 2821-2831.
Crossref
Crossref
Juan C. Villegas, Laura Álvarez‐Montes, Lidia Rodríguez‐Fernández, Jesús González, Rafael Valiente & Mónica L. Fanarraga. (2013) Multiwalled Carbon Nanotubes Hinder Microglia Function Interfering with Cell Migration and Phagocytosis. Advanced Healthcare Materials 3:3, pages 424-432.
Crossref
Crossref
Houshang Amiri, Kolsoum Saeidi, Parvin Borhani, Arash Manafirad, Mahdi Ghavami & Valerio Zerbi. (2013) Alzheimer’s Disease: Pathophysiology and Applications of Magnetic Nanoparticles as MRI Theranostic Agents. ACS Chemical Neuroscience 4:11, pages 1417-1429.
Crossref
Crossref
Juliana B. Hoppe, Karine Coradini, Rudimar L. Frozza, Claudia M. Oliveira, André B. Meneghetti, Andressa Bernardi, Elisa Simões Pires, Ruy C.R. Beck & Christianne G. Salbego. (2013) Free and nanoencapsulated curcumin suppress β-amyloid-induced cognitive impairments in rats: Involvement of BDNF and Akt/GSK-3β signaling pathway. Neurobiology of Learning and Memory 106, pages 134-144.
Crossref
Crossref
Chaoxu Li & Raffaele Mezzenga. (2013) The interplay between carbon nanomaterials and amyloid fibrils in bio-nanotechnology. Nanoscale 5:14, pages 6207.
Crossref
Crossref
Lajos Baranyi & Boro Dropulic. 2013. Mesenchymal Stem Cell Therapy. Mesenchymal Stem Cell Therapy
271
320
.
Anna A. Shvedova, Antonio Pietroiusti, Bengt Fadeel & Valerian E. Kagan. (2012) Mechanisms of carbon nanotube-induced toxicity: Focus on oxidative stress. Toxicology and Applied Pharmacology 261:2, pages 121-133.
Crossref
Crossref
I.G. Kondrasheva, T.A. Antipova, G.G. Barsegyan, P.Ye. Gambaryan, A.A. Guseva & A.A. Kamensky. (2012) Efficacy and Safety of Nasal Administration of “Na-no-L-DOPA” Based on PLGA Nanoparticles. Engineering 04:10, pages 27-29.
Crossref
Crossref
Ajay Vikram Singh, Manish Khare, W. N. Gade & Paolo Zamboni. (2012) Theranostic Implications of Nanotechnology in Multiple Sclerosis: A Future Perspective. Autoimmune Diseases 2012, pages 1-12.
Crossref
Crossref
Hari Shanker Sharma, Rudy J. Castellani, Mark A. Smith & Aruna Sharma. 2012. New Perspectives of Central Nervous System Injury and Neuroprotection. New Perspectives of Central Nervous System Injury and Neuroprotection
47
90
.